This offer is open only to investors that are “accredited investors” (as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”)) that are also “qualified purchasers” within the meaning of Section 2(a)(51)(A) of the United States Investment Company Act of 1940, as amended (the “Investment Company Act”).
An exciting new opportunity is available for investors to express interest in an investment in a new Elon Musk company - xAI - working on building artificial intelligence to accelerate human scientific discovery. As at the end of last month xAI is closing in on nearly raising US6bio in capital against a US18bio valuation.
Our partners in the US have secured this investment opportunity and Syndex is proud to facilitate this offer to eligible investors. xAI is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S.
This offer to express interest in this opportunity closes on May 31st 2024, to register your interest please click the button below.
